Loading...

CStone Pharmaceuticals

CSPHFPNK
Healthcare
Biotechnology
$1.01
$0.00(0.00%)
U.S. Market opens in 16h 27m

CSPHF News Today: Stay Updated with the Latest CStone Pharmaceuticals News in Real Time

Find CSPHF news now at Meyka AI. Stay informed with the latest CStone Pharmaceuticals stocks updates, including price news, market analysis, and expert insights.

SANN.SW stock drops 5.65% in after-hours trading on May 4
📅 7 minutes ago

SANN.SW stock drops 5.65% in after-hours trading on May 4

SANN.SW stock falls 5.65% to CHF17.04 in after-hours trading. Santhera Pharmaceuticals faces headwinds on SIX exchange.

Read more
T14.SI Stock Surges 9.66% on May 4, 2026 – Tianjin Pharmaceutical Gains
📅 2 hours ago

T14.SI Stock Surges 9.66% on May 4, 2026 – Tianjin Pharmaceutical Gains

T14.SI stock jumps 9.66% to S$3.52 on Singapore Exchange. Tianjin Pharmaceutical Da Ren Tang shows strong momentum with 188,000 shares traded.

Read more
PHASQ Stock Crashes 99% on May 4, 2026 After Bankruptcy
📅 2 hours ago

PHASQ Stock Crashes 99% on May 4, 2026 After Bankruptcy

PHASQ stock plummets 99% to $0.000001 on PNK exchange. PhaseBio Pharmaceuticals faces severe losses after Chapter 11 filing in 2022.

Read more
INDV Insider Trade: Barry Patrick Sells Restricted Stock Units, May 04, 2026
📅 3 hours ago

INDV Insider Trade: Barry Patrick Sells Restricted Stock Units, May 04, 2026

Barry Patrick A, Chief Commercial Officer at Indivior (INDV), received 130,312 restricted stock units on January 7, 2026.

Read more
4883.T Stock Plunges 17.5% on May 4, 2026 – Modalis Therapeutics Falls
📅 5 hours ago

4883.T Stock Plunges 17.5% on May 4, 2026 – Modalis Therapeutics Falls

4883.T stock crashes 17.5% to ¥66.0 on JPX. Modalis Therapeutics faces heavy selling pressure amid weak fundamentals and negative analyst ratings.

Read more
KNSA Insider Buying: CEO Patel Acquires 48,565 Shares May 04, 2026
📅 7 hours ago

KNSA Insider Buying: CEO Patel Acquires 48,565 Shares May 04, 2026

Kinikska Pharmaceuticals CEO Sanj K Patel acquires 48,565 Class A shares at $30.93 on May 1, 2026. Insider buying signal worth $1.5M.

Read more
FENC Director Raykov Rosty Sells 15,598 Shares on May 01, 2026
📅 8 hours ago

FENC Director Raykov Rosty Sells 15,598 Shares on May 01, 2026

Fennec Pharmaceuticals director Raykov Rosty sold 15,598 stock options at $2.45 per share on May 01, 2026, totaling $38,215.

Read more
RMCL.BO Stock Surges 9900% on May 4, 2026: BSE High Volume Mover
📅 9 hours ago

RMCL.BO Stock Surges 9900% on May 4, 2026: BSE High Volume Mover

RMCL.BO stock jumps 9900% to INR 195 on BSE with 59,077 volume. Radha Madhav Corporation Limited packaging stock analysis.

Read more
ALNY Earnings Beat: Alnylam Crushes Q1 2026 Estimates
📅 3 days ago

ALNY Earnings Beat: Alnylam Crushes Q1 2026 Estimates

Alnylam Pharmaceuticals (ALNY) crushed Q1 2026 earnings with EPS of $1.51 vs $0.90 estimate, up 68.72%. Revenue hit $1.17B, beating by 4.63%.

Read more

CSPHF News FAQ